Kyowa Kirin is continuing to monitor the COVID-19 outbreak. Learn More
1.Visually inspect drug product solution for particulate matter and discoloration prior to administration. POTELIGEO is a clear to slightly opalescent colorless solution. Do not use the vial if cloudiness, discoloration, or particulates are observed.
2.Calculate the dose (mg/kg) and number of vials of POTELIGEO needed to prepare the infusion solution based on patient weight. Each vial contains 20 mg of POTELIGEO, which is enough for 20 kg of body weight.
3.Aseptically withdraw the required volume of POTELIGEO into the syringe and transfer into an intravenous (IV) baga containing 0.9% Sodium Chloride Injection, USP. The final concentration of the diluted solution should be between 0.1 mg/mL and 3.0 mg/mL.
4.Mix diluted solution by gentle inversion. Do not shake. After preparation, infuse the POTELIGEO solution immediately, or store under refrigeration at 2°C to 8°C (36°F to 46°F) for no more than 4 hours from the time of infusion preparation. Do not freeze. Do not shake.
5.Discard any unused portion left in the vial.
For more information on dosing, see the POTELIGEO Dosing and Administration Guide
Resource for you to use while counseling patients on what to expect during treatment,
see the POTELIGEO Patient Scheduling and Monitoring Treatment Guide
Important Safety Information